Merit Medical Acquires Solo Pace for TAVR Pacing Technology

Merit Medical has acquired Solo Pace, Inc., expanding its cardiac therapies platform with TAVR pacing technology.

According to Manilatimes, Solo Pace specializes in temporary pacing solutions and systems designed for transcatheter heart valve procedures. The procedures cited include transcatheter aortic valve replacement, also known as TAVR.

Transaction Centers on Cardiac Therapies

Manilatimes reported that Merit Medical acquired Solo Pace as part of an expansion of its cardiac therapies platform. The publisher characterized Solo Pace’s offering as innovative TAVR pacing technology.

The announcement places temporary pacing within the context of transcatheter heart valve procedures. Solo Pace’s specialization includes both temporary pacing solutions and systems designed for those procedures, according to Manilatimes.

For medical device sales professionals focused on cardiovascular care, the reported transaction links Merit Medical’s cardiac therapies platform with technology intended for a defined procedural setting: transcatheter heart valve procedures, including TAVR.

Temporary Pacing and Transcatheter Procedures

Manilatimes identified transcatheter aortic valve replacement among the procedures for which Solo Pace’s solutions and systems are designed. The acquisition announcement specifically highlights TAVR pacing technology alongside Merit Medical’s cardiac therapies platform.

The evidence provided does not describe product specifications, clinical outcomes, integration plans, customer availability, or commercial terms. It does establish the procedural focus cited by Manilatimes: temporary pacing for transcatheter heart valve procedures.

Key Points Reported by Manilatimes

• Merit Medical acquired Solo Pace, Inc.
• Solo Pace specializes in temporary pacing solutions and systems.
• Its systems are designed for transcatheter heart valve procedures.
• Transcatheter aortic valve replacement is among the procedures cited.
• The acquisition expands Merit Medical’s cardiac therapies platform with TAVR pacing technology.

The event is framed by Manilatimes around Merit Medical’s cardiac therapies platform and Solo Pace’s temporary pacing specialization for transcatheter heart valve procedures.

Sales Context

The announcement gives cardiovascular device professionals a focused development to follow: the addition of Solo Pace’s temporary pacing specialization to Merit Medical’s cardiac therapies platform. Based on the report, TAVR is the named procedural context for the technology.